We demonstrate that murine myeloma cells can efficiently mediate homologous recombination. The murine myeloma cell line J558L was shown to appropriately recombine two transfected DNA molecules in 30% of cells that received and integrated intact copies ofboth molecules. This activity was then exploited to direct major reconstructions of an endogenous locus within a hybridoma cell line. Production of antigenspecific chimeric heavy chain was achieved by targeting the human IgG1 heavy chain constant region (Cyi) exons to the genomic heavy chain locus of a hybridoma cell line secreting antibody specific for a human tumor-associated antigen. The frequency of productive genomic recombinations was 1 in 200 transfectants, with accumulation of the chimeric protein reaching >20 ,ug/ml in culture supernatants.
Immunoglobulins (Igs) are the subject of much investigation, particularly for the treatment of human tumors. Monoclonal antibodies (mAbs) specific for human tumor-associated antigens are most readily obtained from murine immunization and hybridoma technology (1-3) and many have been generated (4) . The use of such antibodies for human therapy is somewhat limited due to the xenogeneic (foreign) nature of the molecule. Thus, efforts have been made to replace substantial portions ofthe murine molecule with sequences of human origin (5) (6) (7) (8) (9) (10) (11) (12) (13) . Such genetically "re-engineered" proteins have been referred to as "chimeric" antibodies and are expected to be less immunogenic in man. Additionally , it has been demonstrated that for some specificities, replacing the heavy chain constant regions of a mouse Ig molecule with those of human IgG1, in particular, can greatly increase the ability of the molecule to interface with human effector cells in the mediation of antibody-dependent cellular cytotoxicity (ADCC) and improve human complement-mediated tumor cell lysis (10, 11) . The specific binding of Igs also affords one the opportunity to genetically link other biologically active peptides that may be therapeutically useful (14) (15) (16) . The standard molecular genetic techniques for performing these modifications involve the identification and cloning of the productive Ig variable region gene segments, in vitro reconstruction of the genes, subsequent transfection into a suitable cell line for expression, and extensive screening for cell lines that offer stable production at appreciable levels.
Homologous recombination refers to the ability of cells to join together pieces of DNA that have regions of very similar or identical sequence. Several reports describe the use of homologous recombination to activate mutated genes or to inactivate genes within the genome of eukaryotic cells (17) (18) (19) (20) (21) (22) . Various cell types have been studied and successful targeting frequencies have ranged from 1 in 100,000 to 1 in 100. Reported here is an analysis of the capability of murine hybridoma cells to mediate homologous recombination events and the use of this process to direct the production of a fusion protein consisting of a mAb with a mouse-human chimeric heavy chain.
MATERIALS AND METHODS
Cell Lines. The mouse myeloma cell line J558 produces whole IgA antibody, and the mutant J558L line produces only light chain (23) . The murine hybridoma cell line L20 produces antibody reactive with many lung and breast carcinomas (4). The H2981 cell line was derived from pleural effusion of a patient with adenocarcinoma of the lung and adapted to in vitro culture (4).
DNA Transfection. For the J558L cell line, 107 cells were transfected by electroporation (using a Gene Pulser; BioRad) with roughly equimolar ratios of the two DNA molecules, totaling 50 ,ug. Experiment 1 was performed using 600 V with a capacitance of 25 ,Fd, and experiment 2 was performed using 220 V and 960 tFd, in isotonic phosphatebuffered saline (PBS). Forty-eight hours after transfection the cells were seeded into 96-well plates at 104 cells per well. Selection was carried out in RPMI medium (GIBCO) containing 10% (vol/vol) fetal bovine serum and G418 (0.5 mg/ml; GIBCO). The number of integration events analyzed (N) was determined from outgrowth of a single plate seeded at 103 cells per well. The L20 cell line (4) was electroporated at 210 V and 960 ,uFd in PBS and plated in the same fashion. Selection was performed in the presence of G418 (2.5 mg/ ml).
Detection of Secreted Ig by ELISA. Culture supernatants were screened for antibody by using a sandwich ELISA assay either with goat anti-mouse IgA (mIgA) (Cappel Laboratories) as a capture reagent and goat anti-mIgA conjugated to horseradish peroxidase (Cappel Laboratories) to detect or with goat anti-human IgG (hulgG) (Antibodies, Inc.) to capture and goat anti-hulgG conjugated to horseradish peroxidase (American Qualex, LaMirada, CA) to detect. ELISA plates were developed with 3,3',5,5'-tetramethylbenzidine (TMB) chromagen (Genetic Systems, Seattle, WA).
Western Blot Analysis. Western blot analysis was performed as described (28) . Serum-free supernatants (10 ml) from the transfectant and parent cell lines indicated were dialyzed against 100 mM NH4OAc and subjected to SDS/ polyacrylamide gel electrophoresis through 5-15% gradient gels along with 1 jig of purified mIgA (TEPC 15 
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-0. (25) . DNA was isolated from the cell lines indicated, digested with the restriction endonuclease BamHI, subjected to electrophoresis through a 0.6% agarose gel, and transferred to nitrocellulose. The filter was first hybridized (Upper) with a labeled Pst I/HindIII fragment bearing the heavy chain constant region 1 (CHO) gene segment of human Cyl (26) . The hybridization probe was then removed and the filter was rehybridized (Lower) with a HindIll fragment containing the murine heavy chain joining region 2 and 3 (mJ2-3) gene segments (27) . Both probes are shown in A. Production of hulgG (G) and/or migA (A) by each cell line is indicated (Lower). The 10.5-kb fragment that hybridized to both probes is indicated. Other fragments hybridizing to the human C,1 probe represent integration of the unrecombined plasmid into various regions of the genome. The 25-kb fragment that hybridizes only to the mJ2_3 probe, consistent with the uninterrupted IgA gene, is indicated (Lower). The 1-kb fragment indicated corresponds to the region just downstream of the variable region gene segment in the J558 functional heavy chain allele (seen in all cell lines except J558L). The fragment >25 kb observed in DNA from the 16B11 cell line indicates integration of a disrupted copy of the phage clone into the genome. All fragments observed are shown. (C) Western blot analysis of secreted 1g. Serum-free supernatants from the cell lines indicated were prepared and compared with 1 ,ug (or amounts stated) of purified hulgG and mIgA. The gel was transferred to nitrocellulose and stained with goat antiserum specific for hulgG (GahulgG) (Upper) and then with antiserum recognizing mlgA (GamIgA) (the dual stain is shown) (Lower). Note that although the 17F2 cell line originally produced migA and retained the 25-kb fragment associated with the intact phage clone (above in B), these cells were not clonal (as shown by the lower intensity of the 25-kb fragment relative to the recombined 10.5-kb fragment), and production of mIgA had abated by the time the Western blot analysis was performed. Likewise, the 16C7 cell line was a mixed population indicated by the low intensity of the 10.5-kb recombined fragment. cell line (supplied by D. Yelton, Oncogen) as standards. Gels were electroblotted onto nitrocellulose and the resulting filters were blocked and stained with goat anti-hulgG conjugated to horseradish peroxidase (GahuIgG) (Antibodies, Inc.) or with goat anti-mIgA conjugated to horseradish peroxidase (GamIgA) (Cappel Laboratories).
ADCC Comparison. ADCC experiments were performed as described (19 gene segment in the phage clone (Fig. 1A) . The human Cy1
exons are not associated with a variable region gene segment and are, therefore, not functional with respect to expression of human IgG1 heavy chain protein (IgG-). However, recombination between the homologous sequences of the plasmid and phage provides an active transcriptional promoter, translation initiation codon, and splice donor sequence from the variable region of the phage clone (Fig. 1A) . The plasmid also contained the neomycin-resistance gene, and thus transfectants of the Ig heavy chain-deficient cell line J558L (23), which survived selection in G418, were screened for production of mIgA and hulgG. The results of two transfections are presented in Table 1 . All cells that survived the selection are assumed to have received and stably integrated at least one copy of the plasmid, whereas only those cells observed to produce human or mouse Ig can be assumed to have introduced a functional copy of both the phage clone and the plasmid. The observed frequency of appropriate recombination between the two DNA molecules is, therefore, determined by the relative frequency of production of hulgG vs. mIgA. Analysis of more than 100 Ig heavy chain-producing cell lines demonstrated that homologous recombination between the two molecules and integration of the recombinant occurred at a frequency of 30O%.
The expected recombined DNA product was observed by genomic Southern analysis. A 10.5-kb BamHI fragment that hybridized to murine heavy chain joining region (JH) sequences not present on the plasmid clone and to human C,,1 sequences that do not exist on the phage DNA, was detected in DNA from cell lines expressing hulgG (Fig. 1B) . Cells that expressed mIgA retained the uninterrupted 25-kb BamHI fragment that hybridizes to the murine JH probe only (Fig. 1B  Upper) . Both mIgA-and hulgG-expressing cell lines (as well as the J558 parent) have the 1-kb fragment characteristic of the area just downstream of the functional J558 variable region gene segment (Fig. 1B Lower) . Fig. 3A was linearized at the Xba I site, and 50 ,ug was used to transfect 8 x 106 cells of the murine hybridoma cell line L20 (4).
The recombinant heavy chain protein was shown to be of the expected size and distinct from the mIgA with respect to size and serology, by Western blot analysis (Fig. 1C) . Staining with a goat anti-hulgG antiserum identified a 55-kDa polypeptide chain in supernatants that tested positive for human Ig in ELISA assays, but the slightly larger mIgA was not seen with this antiserum.
This demonstrates that the production of serologically detectable hulgG results from recombination between homologous sequences of the cotransfected molecules. This method of analysis thus serves as a reliable assay for homologous recombination activity and could be applied to further study of the enzymatic machinery that mediates such reactions.
The extent to which the homologous recombination activity could be used to genetically reconstruct the endogenous Igh locus within a hybridoma genome was then explored. A plasmid vector similar to that used in the J558L experiments was again used as a target sequence-a 2.3-kb region of the murine Igh locus located upstream of the switch region ( Fig.  2A) . This segment is held in common among all functional murine heavy chain loci, regardless of specificity or isotype expression. The vector was linearized at a unique Xba I site within the target sequence and transfected into the hybridoma cell line L20 that produces a murine IgG1 antibody specific for an antigen expressed primarily on human carcinoma cells (4) . Cells surviving selection in medium containing G418 were assayed for production of human IgG1 by ELISA. The frequency of integration events resulting in production of human IgG1 in two experiments was observed to be -1 in 200 transfectants (Table 2) .
Identical patterns of plasmid integration were observed between cell lines that expressed human IgG1. Genomic Southern blot analysis was performed comparing DNA from the L20 parent and transfectant cell lines using a probe specific for human Cy1. Digestion with several restriction enzymes revealed integration-site-specific fragments in common between cell lines producing human IgG1 (Fig. 2B) , indicating that the plasmid integrated into the same site within each of these subclones (derived from three cell lines). Integration events not associated with the production of human IgG1 yield differently sized fragments (e.g., 8F8-10 in Fig. 2B ). Fragments equal to the unit size of the plasmid (10.2 kb) are observed in DNA from most clones (including 8F8-10) digested with enzymes that cleave the plasmid once (e.g., BgI II and Sst I; Fig. 2B ), indicating tandem copies. Likewise, the 7.6-kb BamHI fragment present in most clones is consistent with a head to tail arrangement of the multiple copies (Fig. 2B  Lower) . Thus most clones producing human IgG1 have integrated multiple copies of the vector in a head to tail configuration at the single site of integration, although clones can be found that retain a single copy of the recombined plasmid (e.g., clone 8H12.1 in Fig. 2) .
Clonal cell lines were established that expressed the chimeric protein, the murine Ig, or both, suggesting that the parental cells retained more than one copy of the productive heavy chain gene. The chimeric heavy chain secreted by transfectants was shown to be uniformly of the expected size and serologically distinct from the murine Ig by Western blot analysis (Fig. 3A) . Goat anti-hulgG antiserum detects a 55-kDa polypeptide chain that comigrates with purified human IgG1 heavy chain in serum-free supernatants from clones that test positive for hulgG in ELISA assays. This polypeptide is not found in supernatants from the untransfected L20 cell line or from transfectants that produce only murine Ig as detected by ELISA (e.g., 8F8-10 and 10G3-5; Fig. 3A ). Restaining this filter with antiserum specific for murine Ig confirmed the presence of the murine protein that migrates at the same position (data not shown). mAb bearing the chimeric heavy chain was purified with protein ASepharose from supernatants of the 7E6-10 subclone (which produces no murine heavy chain) and found to have a migration pattern distinct from the murine IgG1 but identical to another IgG1 chimeric mAb (created by cloning and reconstruction) in agarose gels with a 0.5 ionic strength barbitol buffer (pH 8.6) (data not shown). Flow cytometric analysis using fluorescein isothiocyanate (FITC)-labeled antiserum specific for human Ig demonstrated that antibody bearing chimeric heavy chain from each of the eight parental cell lines obtained from experiment 1 ( Table 2 ) bound to tumor cells that bear the L20 antigen but not to L20-negative cell lines (data not shown). The heavy chain chimeric mAb purified from 7E6-10 (HCCL20) was then used to specifically block the binding of FITCconjugated murine L20 mAb to H2981 tumor cells (Fig. 3B) , formally demonstrating that binding is specific for the L20 antigen.
The murine L20 mAb was then compared with heavy chain chimeric L20 (HCCCL20) for ability to mediate tumor-cell destruction by ADCC in the presence of human effector cells (Fig. 3C) . Killing was achieved in a dose-dependent fashion using HCCL20 but not with L20 mAb, demonstrating that replacement of the murine yl heavy chain constant regions with those of human IgG1 provides an effector function to this specificity. It is thus not always necessary to replace the constant region of the light chain to provide and assess new effector functions.
The growth and Ig production characteristics were compared for a transfected clone producing antibody with the chimeric heavy chain (7E6-10) and the untransfected L20 cell line (Fig. 3D) . Ig accumulation reached levels of 21 and 42 ,ug/ml in 9-day culture supernatants of 7E6-10 and L20 cells, respectively. Therefore, integration of the vector sequences within the Ig locus maintains structural characteristics necessary to achieve high levels of expression of the chimeric protein. These levels may be further improved through clonal selection for high producers, as had been done for the murine L20 cell line.
This study demonstrates that murine myeloma cells are capable of mediating homologous recombination events at high frequencies and that this activity can be used to modify the Igh locus within the genome of hybridoma cells to direct production of antibody fusion proteins, thus obviating the necessity of cloning heavy and light chain variable region gene segments. The vector described here employs sequences located upstream of the Ig switch recombination region. Therefore, rapid reconstruction of the Igh locus can be effected within hybridoma cell lines regardless of specificity or isotype (unpublished results), and targeting to this region also precludes deletion of introduced sequences by potential switch recombination events. Thus, rapid evaluations of effector functions can be assessed for mAbs of many specificities. It should also be possible to replace light chain constant regions in a similar fashion and perhaps to construct vectors that would direct the generation of Fab molecules or modifications conferring improved effector functions, such as biologic modifiers or enzymes. Additional strategies involving homology downstream of regions to be replaced (gene replacement vectors) may also prove useful and result in even higher frequencies of the desired recombination.
Expression levels of in vitro constructed recombinant proteins, such as chimeric Ig, have tended to be much lower than in the in situ reconstruction described here. Baker and Shulman (33) demonstrated that a light chain variable region could be replaced at comparable frequencies. Thus it may prove useful to transplant cloned variable regions into host cells expressing high levels of Ig of a desired isotype. Additionally, the Igh locus within a hybridoma cell may also serve as an ideal site to target other genes requiring mammalian expression.
